CorMedix (CRMD) Net Margin (2013 - 2025)

CorMedix's (CRMD) quarterly Net Margin came in at 10.9% in Q4 2025, down 9333.0% year-on-year from 0.12% in Q4 2024, and down 89.53% quarter-over-quarter from 104.08% in Q3 2025.

CorMedix (CRMD) Net Margin (2013 - 2025) Analysis & Trends

CorMedix has disclosed Net Margin across 12 years of filings, most recently posting 10.9% for Q4 2025.

  • Net Margin for Q4 2025 came in at 10.9%, down 9333.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 52.95% (up 5034.0% YoY), and the FY2025 annual result was 52.31%, up 4970.0% from the prior year.
  • Net Margin came in at 10.9% for Q4 2025 at CorMedix, down from 104.08% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 91671.03% in Q1 2022 to a low of 100538.67% in Q3 2022.
  • The 4-year median for Net Margin is 55.0% (2025), against an average of 4503.76%.
  • Peak annual rise in Net Margin reached 8351341 bps in 2022, while the deepest fall reached 12311796 bps in 2022.
  • CorMedix's Net Margin stood at 17141.29% in 2021, then tumbled by 61 bps to 27637.7% in 2022, then jumped by 100 bps to 104.23% in 2024, then sank by 90 bps to 10.9% in 2025.
  • The last three Net Margin figures came in at 10.9% (Q4 2025), 104.08% (Q3 2025), and 55.0% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 34.53%
9 Abivax 91.71 Bn 91.71 Bn - -
10 CorMedix 631,378.03 -154.57 Mn 107.31 Mn 10.90%

Historic Data

Download Data
DateValue
Dec 31, 2025 10.90%
Sep 30, 2025 104.08%
Jun 30, 2025 55.00%
Mar 31, 2025 52.82%
Dec 31, 2024 104.23%
Sep 30, 2024 -24.24%
Jun 30, 2024 -1,755.51%
Dec 31, 2022 -27,637.70%
Sep 30, 2022 -100,538.67%
Jun 30, 2022 35,759.66%
Mar 31, 2022 91,671.03%
Dec 31, 2021 -17,141.29%
Sep 30, 2021 22,579.29%
Jun 30, 2021 56,159.20%
Mar 31, 2021 8,157.62%
Dec 31, 2020 -68,075.68%
Sep 30, 2020 7,095.25%
Jun 30, 2020 23,110.14%
Mar 31, 2020 7,562.05%
Dec 31, 2019 -21,406.83%